CASE DISCUSSION
Therapeutic options for MRSA
Presented India by Dr. Rishabh Kumar MittalViews
44,413
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Methicillin-resistant Staphylococcus aureus (MRSA) infections present significant therapeutic challenges due to their resistance to commonly used antibiotics. Effective treatment options include the use of antibiotics such as vancomycin, daptomycin, and linezolid, which are specifically targeted...
Case Summary
- MRSA (Methicillin-resistant Staphylococcus aureus) is a prominent organism in Western countries, while its prevalence is lower in India and Southeast Asia. Despite this, drugs used for empirical MRSA coverage are often overused in intensive care settings. Understanding the appropriate use of various therapeutic options is crucial for clinicians.
Speaker Profile
Dr. Rishabh Kumar Mittal
Alumni- Fortis Escorts Heart InstituteDr. Rishabh Kumar Mittal is a senior Critical Care specialist with expertise in managing critically ill patients in intensive care settings.
He serves as Principal Consultant and Incharge of the Gastro-Liver and Liver Transplant ICU at Max Super Speciality Hospital.
His clinical focus includes advanced critical care management, multi-organ failure, and perioperative care of liver transplant patients.
He is experienced in handling complex ICU protocols and high-risk gastro-hepatic critical cases.
Through his work, he contributes to improving outcomes in transplant and critical care medicine with a multidisciplinary approach.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.